Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

3 Nov 2009 07:00

Embargoed Release: 07:00hrs, Tuesday 3rd November 2009

SOPHEON PLC ("Sopheon" or the "Company") INTERIM MANAGEMENT STATEMENT

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, issues its interim management statement for the period since 1 July 2009 to the date of this announcement, in line with the requirements of the EU Transparency Directive.

Sopheon's revenue visibility* has increased to 7.6m. This compares to visibility of 8.1m at this time last year, representing a headline drop of 7%. Although the tough economic environment of the last few quarters is showing some signs of improvement, sales cycles generally remain protracted, and pricing is still under pressure. However, extension business from the customer base has held up well and the pipeline for new business continues to show promising activity, with the potential to make the fourth quarter the strongest of the current year.

In earlier statements, we noted that we had boosted investment in product development with the objective of strengthening our competitive position entering 2010. Having completed a number of new product enhancements, as further described below, we believe that we have achieved this objective. In light of the ongoing tough market conditions, we continue to adopt a conservative stance to our operational planning. This stance has underpinned recent implementation of targeted reductions to our staffing levels, and we continue to keep firm control over all overheads. As previously announced, we have also raised 850,000 of fresh capital in the form of convertible debt, half of which was backed by members of the board and management team.

In making cost adjustments, we have been very careful to preserve our ability to fully pursue our promising sales pipeline. Innovation remains a strategic priority at many corporations. Further, there are clear signs that we are beginning to benefit from the unique capacity of our software to provide all-in-one support for innovation strategy, ideation and execution. We are planning for closure on several transactions by year end, from current clients as well as new customers, which would add to the visibility of 7.6m noted above. Nevertheless, our usual note of caution remains pertinent in these economic times; given the nature and scale of our business, reported results in a particular period can be affected by the timing and size of individual sales.

Sopheon's investment and progress in both product and marketing during the course of 2009 reflect our goal of continued leadership of our chosen markets. Earlier in the year we launched Accolade(R) Idea Lab(TM), the first integrated solution on the market that not only facilitates generation and development of ideas, but makes it possible to seamlessly move those ideas into product development for execution. During October, we completed a major new version of our Accolade(R) Vision Strategist(TM) roadmapping software. Principal advances include greater ease of use, and increased support for collaboration throughout the product planning process. Market launch is scheduled for later this quarter. We are also making significant changes to our core innovation process management software. These changes include the introduction of new portfolio management and resource planning capabilities that will expand our differentiation, and deepen our value proposition. Full market launch is scheduled for the start of 2010, but aspects of these developments are already being test-marketed and sold to new and existing customers. In conjunction with product advancements, we have invested in new marketing capabilities that leverage emerging channels such as social media. These new practices have the promise to fundamentally transform the way in which we identify, create and nurture relationships with existing and potential customers.

* A definition of how visibility is calculated was provided in our announcement of 25 June 2008.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685

735 Arif Karimjee, CFO Vikki Krause Hansard Group Tel : + 44 (0) 207 245 1100 Sarah Jacobs Seymour Pierce Corporate Tel: +44 (0) 20 7107 8000 Finance Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010About Sopheon

Sopheon is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury, Corning, Electrolux, General Motors, Honeywell, Motorola and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

vendor
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.